Edition:
United Kingdom

Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

34.50USD
21 Nov 2017
Change (% chg)

-- (--)
Prev Close
$34.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
136,772
52-wk High
$46.81
52-wk Low
$28.49

Latest Key Developments (Source: Significant Developments)

Repligen reports Q3 adjusted non-GAAP earnings per share $0.15
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Repligen Corp :Repligen reports third quarter 2017 financial results.Q3 adjusted non-GAAP earnings per share $0.15.Q3 GAAP earnings per share $0.11.Q3 revenue $36.6 million versus I/B/E/S view $35.3 million.Q3 earnings per share view $0.11 -- Thomson Reuters I/B/E/S.Sees fy 2017 adjusted earnings per share $0.60 to $0.63.Sees fy 2017 GAAP earnings per share $0.38 to $0.41.Repligen Corp sees fy 2017 GAAP gross margin in range of 52.5 pct-53.5 pct​.Repligen Corp - sees fy 2017 revenue in range of $139-$142 million, narrowing previous guidance of $138-$144 million​.Fy2017 revenue view $140.6 million -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $0.59 -- Thomson Reuters I/B/E/S.  Full Article

Repligen extends long term supply agreement with Purolite for Protein A ligands
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Repligen Corp :Repligen extends long term supply agreement with Purolite for Protein A ligands.Repligen Corp - ‍Pursuant to agreement, co will supply Protein A ligands to purolite through November 2022, with an option for renewal through 2025​.Repligen - ‍Pursuant to agreement, Repligen will supply Protein A ligands to Purolite through November 2022, with an option for renewal through 2025​.  Full Article

Repligen prices public offering of shares of common stock
Wednesday, 28 Jun 2017 

June 27 (Reuters) - Repligen Corp ::Repligen Corporation prices public offering of shares of common stock.Says public offering of 2.81 million common shares priced at $42.75 per share.  Full Article

Repligen reports Q2 earnings per share $0.11
Thursday, 4 Aug 2016 

Repligen Corp : Q2 earnings per share $0.11 . Q2 non-GAAP earnings per share $0.16 . Q2 earnings per share view $0.13 -- Thomson Reuters I/B/E/S . Q2 revenue $29.2 million versus I/B/E/S view $24.8 million . Sees FY 2016 GAAP earnings per share $0.23 to $0.29 . Sees FY 2016 adjusted earnings per share $0.42 to $0.48 . Sees FY 2016 revenue $101 million to $105 million .FY2016 earnings per share view $0.47, revenue view $99.4 million -- Thomson Reuters I/B/E/S.  Full Article

Repligen announces pricing of $100 mln of 2.125 pct convertible senior notes due 2021
Thursday, 19 May 2016 

Repligen Corp :Repligen announces pricing of $100 million of 2.125 pct convertible senior notes due 2021.  Full Article

Repligen Corp files for mixed shelf offering - SEC filing
Wednesday, 18 May 2016 

Repligen Corp : Repligen Corp files for mixed shelf offering, size not disclosed Source - http://bit.ly/1WExHpA Further company coverage: [RGEN.O] (Bengaluru Newsroom: +1 646 223 8780).  Full Article

Repligen to offer $100 mln of convertible senior notes
Wednesday, 18 May 2016 

Repligen Corp :Repligen announces proposed public offering of $100 million of convertible senior notes due 2021.  Full Article

Repligen Corp announces extension of long term supply agreement for Protein A
Wednesday, 24 Feb 2016 

Repligen Corp:Announces extension of long term supply agreement for protein a.Says has extended through 2019 a key long-term supply agreement with GE healthcare for the manufacture of protein a ligands.  Full Article